Titlebook: Lupus Erythematosus; Clinical Evaluation Peter H. Schur,Elena M. Massarotti Book 2012 Springer Science+Business Media New York 2012 ANA.Er

娱乐某人

书目名称Lupus Erythematosus影响因子(影响力)




书目名称Lupus Erythematosus影响因子(影响力)学科排名




书目名称Lupus Erythematosus网络公开度




书目名称Lupus Erythematosus网络公开度学科排名




书目名称Lupus Erythematosus被引频次




书目名称Lupus Erythematosus被引频次学科排名




书目名称Lupus Erythematosus年度引用




书目名称Lupus Erythematosus年度引用学科排名




书目名称Lupus Erythematosus读者反馈




书目名称Lupus Erythematosus读者反馈学科排名

BRAND

The Immunopathogenesis and Immunopathology of Systemic Lupus Erythematosus,es can bind protein and nucleic acid components of the cell nucleus to form immune complexes to drive pathogenesis. These complexes can deposit in the kidney to incite nephritis or stimulate plasmacytoid dendritic cells (pDCs) to produce cytokines, most prominently type 1 interferon. The activity of

牌带来

Diagnosing and Monitoring Lupus,affect virtually every organ. The most common pattern is a mixture of constitutional complaints with skin, musculoskeletal, hematologic, and serologic involvement (show Table 3.1). However, some patients have predominately hematologic, renal, cardiopulmonary, or central nervous system manifestations

艰苦地移动

Recommendations on How to Monitor the Patient with Systemic Lupus Erythematosus in the Clinic or atow patients with SLE in the clinic when the disease is mild to moderate and or well controlled. At times patients with SLE are hospitalized and are monitored much more intensively according to extent of their disease activity. In clinical studies investigators frequently use complex outcome measures

chisel

Laconic

Musculoskeletal Manifestations of SLE,iness either at the onset of the disease or later during its course. Yet the frequency of arthralgia or arthritis in lupus populations is quiet variable; for example, in one series described by Fries, it was observed in 53 % of 193 patients, and in the Dubois series, it was described at some time du

箴言

不可比拟

纬线

Hematologic Manifestations of SLE,o provide an overview of potential hematologic complications of SLE, with a focus on the prognostic significance, pathophysiology, workup, and treatment options for lupus-associated anemia, thrombocytopenia, immunological defects, and coagulopathies.

watertight,